These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3098235)

  • 21. Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies.
    Günther A; Schmidt R; Feustel A; Meier U; Pucker C; Ermert M; Seeger W
    Am J Respir Crit Care Med; 1999 Jan; 159(1):244-51. PubMed ID: 9872845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction and characterization of the major surfactant apoprotein during rabbit fetal lung development.
    Snyder JM; Mendelson CR
    Biochim Biophys Acta; 1987 Aug; 920(3):226-36. PubMed ID: 3300784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No evidence for vitamin K-dependent carboxylation of canine surfactant apoproteins, 28-36 kDa.
    Wallin R; Seaton M; Martin LF
    Biochem J; 1988 Jun; 252(3):851-6. PubMed ID: 3421925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.
    Wang Z; Chang Y; Schwan AL; Notter RH
    Am J Respir Cell Mol Biol; 2007 Oct; 37(4):387-94. PubMed ID: 17556674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surfactant apoprotein in adult rat lung compartments is increased by dexamethasone.
    Young SL; Ho YS; Silbajoris RA
    Am J Physiol; 1991 Feb; 260(2 Pt 1):L161-7. PubMed ID: 1996659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An ethanol/ether soluble apoprotein from rat lung surfactant augments liposome uptake by isolated granular pneumocytes.
    Claypool WD; Wang DL; Chander A; Fisher AB
    J Clin Invest; 1984 Sep; 74(3):677-84. PubMed ID: 6547963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysophosphatidylcholine sensitizes lipid extracts of pulmonary surfactant to inhibition by serum proteins.
    Cockshutt AM; Possmayer F
    Biochim Biophys Acta; 1991 Oct; 1086(1):63-71. PubMed ID: 1954245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alveolar type II cells, surfactant protein A (SP-A), and the phospholipid components of surfactant in acute silicosis in the rat.
    Kawada H; Horiuchi T; Shannon JM; Kuroki Y; Voelker DR; Mason RJ
    Am Rev Respir Dis; 1989 Aug; 140(2):460-70. PubMed ID: 2764382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and functional aspects of protein: phospholipid interactions in surfactant.
    Benson BJ; Hawgood S
    Eur J Respir Dis Suppl; 1985; 142():29-36. PubMed ID: 3860394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recycling of surfactant lipid and apoprotein-A studied by electron microscopic autoradiography.
    Young SL; Fram EK; Larson E; Wright JR
    Am J Physiol; 1993 Jul; 265(1 Pt 1):L19-26. PubMed ID: 8338178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of apoprotein and calcium ions in surfactant function.
    Benson BJ; Hawgood S; Williams MC
    Exp Lung Res; 1984; 6(3-4):223-36. PubMed ID: 6436013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase.
    Pison U; Tam EK; Caughey GH; Hawgood S
    Biochim Biophys Acta; 1989 Sep; 992(3):251-7. PubMed ID: 2775786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity.
    Curstedt T; Jörnvall H; Robertson B; Bergman T; Berggren P
    Eur J Biochem; 1987 Oct; 168(2):255-62. PubMed ID: 3665923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of protein, cholesterol, and phosphatidylglycerol on the surface activity of the lipid-protein complex reconstituted from pig pulmonary surfactant.
    Suzuki Y
    J Lipid Res; 1982 Jan; 23(1):62-9. PubMed ID: 6895763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin inhibits the accumulation of the major lung surfactant apoprotein in human fetal lung explants maintained in vitro.
    Snyder JM; Mendelson CR
    Endocrinology; 1987 Apr; 120(4):1250-7. PubMed ID: 3549256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biophysical characterization and modeling of lung surfactant components.
    Ingenito EP; Mark L; Morris J; Espinosa FF; Kamm RD; Johnson M
    J Appl Physiol (1985); 1999 May; 86(5):1702-14. PubMed ID: 10233138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of binding and membrane destabilization of phospholipid membranes by surfactant apoprotein B.
    Chang R; Nir S; Poulain FR
    Biochim Biophys Acta; 1998 May; 1371(2):254-64. PubMed ID: 9630660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural relationship between the two small hydrophobic apoproteins in bovine pulmonary surfactant.
    Yu SH; Chung W; Possmayer F
    Biochim Biophys Acta; 1989 Sep; 1005(1):93-6. PubMed ID: 2775764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary surfactant.
    Possmayer F; Yu SH; Weber JM; Harding PG
    Can J Biochem Cell Biol; 1984 Nov; 62(11):1121-33. PubMed ID: 6395944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.